2 recruiting, 1 not yet recruiting, 1 unknown. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hodgkin Disease Lymphoma: new trials by email Literature Review of Hodgkin Disease Lymphoma trials Research Report on Hodgkin Disease Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sperm Epigenome in Hodgkin Lymphoma Additional semen samples - Hodgkin Disease Lymphoma | Not applicable | Not yet recruiting | Rennes University Hospital | 50 | 2026-06-01 | 2026-05-14 |
| Proton Therapy for Mediastinal Lymphoma (PROMLY) Proton therapy - Mediastinal Lymphoma, Hodgkin Disease Lymphoma | Not applicable | Recruiting | Copenhagen University Hospital, Rigshospitalet | 139 | 2026-05-01 | 2026-09-14 |
| Amping up With PemJAK Ruxolitinib, Pembrolizumab - Non-Hodgkin Lymphoma, Hodgkin Disease Lymphoma | Phase 2 | Recruiting | Seda S. Tolu | 53 | 2025-12-03 | 2025-12-16 |
| A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma Penpulimab, Investigator's choice of Chemotherapy - Hodgkin Disease Lymphoma | Phase 3 | Unknown | Akeso | 60 | 2022-02-15 | 2022-02-17 |
Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphoma, T-Cell, Peripheral (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1)
Proton Therapy (1) · pembrolizumab (1) · penpulimab (1) · ruxolitinib (1)
Akeso (1) · Copenhagen University Hospital, Rigshospitalet (1) · Rennes University Hospital (1) · Seda S. Tolu (1)
China (1) · Denmark (1) · France (1) · United States (1)
Seda Tolu, MD (1) · Yuqin Song, MD (1)